Trazadone 150mg
Company: Teva Pharmaceutical
Approval Status: Approved May 1997
Treatment for: depression
Areas: Endocrinology; Psychiatry/Psychology
General Information
Other Useful Resources
Trazadone 150mg tablets have been approved to manufacture and market as a treatment for depression. Teva previously received approval for 50mg and 100mg dosage strengths. Trazadone is the generic equivalent of Bristol Meyers Squibb’s Desyrel 7.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
